Activation or modulation of bile acid receptors, such as the farnesoid X receptor and TGR5, and transporters, such as the ileal apical sodium-dependent bile acid transporters, are involved in the pathogenesis of insulin resistance and NAFLD. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.